Biotechnology
UnitedHealth’s rough stretch continues, with buyouts, a reported DOJ probe and a 23% drop in three months
FILE PHOTO: The logo of Down Jones Industrial Average stock market index listed company UnitedHealthcare is shown in Cypress, California April 13, 2016. Mike Blake | Reuters UnitedHealthcare is in hot water again as the insurance giant grapples with a reported government investigation of its Medicare billing practices, pursues employee buyouts and potential layoffs and […]
Read More
UnitedHealthcare is offering buyouts to employees in benefits unit, could pursue layoffs, sources say
A general view outside the United Healthcare corporate headquarters on December 4, 2024 in Minnetonka, Minnesota. Stephen Maturen | Getty Images UnitedHealthcare is offering certain employees in its benefits operations unit the option to accept buyouts if they quit by March 3, following a tumultuous year for the insurance giant, CNBC has learned. Those who […]
Read More
Moderna beats on revenue but loses more than expected as it scales down manufacturing
Moderna on Friday posted fourth-quarter revenue that beat estimates, but lost more than expected for the period, as the biotech company continues to slash costs and demand for its Covid vaccine falls. It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the rapid decline […]
Read More
CVS shares are up 45% this year — here’s why it may be starting to turn its business around
The CVS pharmacy logo is displayed on a sign above a CVS Health Corp. store in Las Vegas, Nevada, on Feb. 7, 2024. Patrick T. Fallon | AFP | Getty Images After a dismal 2024, CVS Health could be starting to turn itself around. Some investors seem convinced, especially after the retail drugstore chain on […]
Read More
CVS CEO defends pharmacy middlemen, accuses drugmakers of ‘monopolistic’ practices
David Joyner, a longtime CVS executive, speaks during a Senate Health, Education, Labor and Pensions Committee hearing in Washington, D.C., on May 10, 2023. Al Drago | Bloomberg | Getty Images CVS Health CEO David Joyner on Wednesday defended controversial pharmacy middlemen like his company’s Caremark unit, which are widely accused of inflating prescription medication […]
Read More
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021. Dado Ruvic | Reuters Biogen on Wednesday posted fourth-quarter revenue and profit that topped expectations as its cost cuts showed progress and new products, including its breakthrough Alzheimer’s treatment Leqembi, saw growth. But the biotech company’s […]
Read More
CVS results top estimates even as high medical costs drag down insurance unit
An exterior view of a CVS pharmacy in Danville, Pennsylvania. Paul Weaver | Lightrocket | Getty Images CVS Health on Wednesday reported fourth-quarter revenue and profit that topped estimates, even as its troubled insurance business continued to see higher medical costs. The company also issued a full-year 2025 adjusted earnings outlook of $5.75 to $6 […]
Read More
Trump is unlikely to end Medicare drug price talks — here’s what that means for patients and pharma
President Donald Trump arrives in the Brady Press Briefing Room at the White House on Jan. 30, 2025 in Washington, DC. Oliver Contreras | Afp | Getty Images President Donald Trump likely won’t do away with a landmark process that allows Medicare to negotiate drug prices with manufacturers, even as he moves to erase Joe […]
Read More
Trump 2.0 may create powerful tailwinds for two vastly different groups: big banks and small caps
ETF Edge Trump 2.0 may create powerful tailwinds for two vastly different groups: big banks and small caps Published Sat, Feb 8 202511:00 AM EST WATCH LIVE Source
Read More
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
The Eli Lilly & Co. logo at the company’s Digital Health Innovation Hub facility in Singapore, on Thursday, Nov. 14, 2024. Ore Huiying | Bloomberg | Getty Images Eli Lilly on Thursday said it expects to release data from a late-stage trial on its next-generation weight loss drug retatrutide later this year, which is a […]
Read More